Medartis Holding AG

Swiss Stock Exchange MED.SW

Medartis Holding AG EPS (Diluted) for the year ending December 31, 2023: USD 0.06

Medartis Holding AG EPS (Diluted) is USD 0.06 for the year ending December 31, 2023, a 111.34% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Medartis Holding AG EPS (Diluted) for the year ending December 31, 2022 was USD -0.53, a -183.35% change year over year.
Medartis Holding AG EPS (Diluted) for the year ending December 31, 2021 was USD 0.64, a 801.74% change year over year.
Medartis Holding AG EPS (Diluted) for the year ending December 31, 2020 was USD -0.09, a -148.76% change year over year.
Medartis Holding AG EPS (Diluted) for the year ending December 31, 2019 was USD 0.19, a -54.23% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Swiss Stock Exchange: MED.SW

Medartis Holding AG

CEO	Mr. Matthias Schupp
IPO Date	March 23, 2018
Location	Switzerland
Headquarters	Hochbergerstrasse 60E
Employees	860
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

Key trends

Past 5 years